Literature DB >> 9244214

Late regression of the dilated site after coronary angioplasty: a 5-year quantitative angiographic study.

J A Ormiston1, F M Stewart, A H Roche, B J Webber, R M Whitlock, M W Webster.   

Abstract

BACKGROUND: Limited data are available on the changes that occur at the dilated site late after coronary angioplasty. The aim of this study was to evaluate with quantitative angiography the natural history of changes that occur in the dilated segment between "early" (approximately 6 months) and "late" (approximately 5 years) follow-up after angioplasty. METHODS AND
RESULTS: Of 127 consecutive patients (174 lesions) with successful angioplasty, 125 underwent early angiography. Three patients subsequently died, and 24 underwent revascularization surgery or repeated angioplasty, giving a study-eligible population of 98 patients. Quantitative angiographic analysis was performed before and immediately after angioplasty and at early and late follow-up in the study population of 84 patients (115 lesions), which was 86% of study-eligible patients. Mean lesion diameter stenosis decreased from 36.3+/-14.2% at early to 29.6+/-13.5% at late follow-up (P<.0001). No lesion developed late restenosis by the 50% diameter loss criterion. Late regression was related to stenosis severity at early angiography (r=-.58, P<.001). Subgroups at early angiography of 40% to 49% stenosis and > or = 50% stenosis showed significant regression at late angiography.
CONCLUSIONS: Lesion regression at the dilated site is common late after angioplasty. The more severe a stenosis is at early angiography, the more likely the chance that there will be late regression. A strategy of watchful waiting may be appropriate for patients with restenotic lesions of borderline severity.

Entities:  

Mesh:

Year:  1997        PMID: 9244214     DOI: 10.1161/01.cir.96.2.468

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Serial six year quantitative angiographic follow up in asymptomatic patients following successful coronary angioplasty.

Authors:  Y Takeda; T Kobayashi; N Awata; S Sato; J H C Reiber; T Nakagawa; E Tsuchikane; O Katoh; M Kirino; T Kobayashi; K Yachiku; N Shibata
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

2.  Cobalt-chromium stents in long lesions of large vessels: clinical and angiographic results.

Authors:  Iñigo Lozano; Carlos Cuellas; Pablo Avanzas; Armando Pérez de Prado; Concepción Suárez; Juan Rondan; Daehyun Lee; Jesus M de la Hera; Felipe Fernández; César Morís
Journal:  Tex Heart Inst J       Date:  2011

Review 3.  Pathology of Endovascular Stents.

Authors:  Kenta Nakamura; John H Keating; Elazer Reuven Edelman
Journal:  Interv Cardiol Clin       Date:  2016-05-19

4.  Lack of association between baseline plasma homocysteine concentrations and restenosis rates after a first elective percutaneous coronary intervention without stenting.

Authors:  C-K Wong; C J K Hammett; R The; J K French; W Gao; B J Webber; J M Elliott; A W Hamer; J A Ormiston; M W I Webster; R A H Stewart; R V Ameratunga; H D White
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

5.  Distance from the coronary ostium to the culprit lesion in acute ST-elevation myocardial infarction and its implications regarding the potential prevention of proximal plaque rupture.

Authors:  C Michael Gibson; Ajay J Kirtane; Sabina A Murphy; Juhana Karha; Christopher P Cannon; Robert P Giugliano; Mathew T Roe; Robert A Harrington; E Magnus Ohman; Elliott M Antman
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

6.  Development of a polycaprolactone/poly(p-dioxanone) bioresorbable stent with mechanically self-reinforced structure for congenital heart disease treatment.

Authors:  Fan Zhao; Jing Sun; Wen Xue; Fujun Wang; Martin W King; Chenglong Yu; Yongjie Jiao; Kun Sun; Lu Wang
Journal:  Bioact Mater       Date:  2021-03-01

Review 7.  Bioresorbable drug-eluting magnesium-alloy scaffold for treatment of coronary artery disease.

Authors:  Carlos M Campos; Takashi Muramatsu; Javaid Iqbal; Ya-Jun Zhang; Yoshinobu Onuma; Hector M Garcia-Garcia; Michael Haude; Pedro A Lemos; Boris Warnack; Patrick W Serruys
Journal:  Int J Mol Sci       Date:  2013-12-16       Impact factor: 5.923

8.  Bioresorbable scaffolds in the treatment of coronary artery disease.

Authors:  Yaojun Zhang; Christos V Bourantas; Vasim Farooq; Takashi Muramatsu; Roberto Diletti; Yoshinobu Onuma; Hector M Garcia-Garcia; Patrick W Serruys
Journal:  Med Devices (Auckl)       Date:  2013-03-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.